SEC Form 4 · accession 0001447348-15-000036
PROGENICS PHARMACEUTICALS INC · PGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Israel
Officer — Executive Vice President, Medi
Period of report
Jun 11, 2015
Accepted (ET)
Jun 15, 2015 · 9:32 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000835887
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 11, 2015 | M | 2,000 | $5.33 | A | 37,050 | D | |
| Common StockF1 | Jun 11, 2015 | S | 2,000 | $6.83 | D | 35,050 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $5.33 | Jun 11, 2015 | M | 2,000 | D | Jul 1, 2010 | Jul 1, 2019 | Common Stock | 2,000 | 4,000 | D |
Explanation of responses
- F1The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.